El-Serag Hashem B, Gilger Mark, Carter Junaia, Genta Robert M, Rabeneck Linda
Section of Health Services Research, The Houston Veterans Affairs Medical Center, Houston, Texas 77030, USA.
Am J Gastroenterol. 2004 May;99(5):806-12. doi: 10.1111/j.1572-0241.2004.30098.x.
OBJECTIVE: The clinical course of gastroesophageal reflux disease (GERD) in children without comorbid illness (neurological deficits, congenital esophageal anomalies, chronic obstructive airway conditions) is unclear. Whether GERD in childhood progresses or predisposes to GERD in adulthood remains unknown. METHODS: We identified a cohort of individuals endoscopically diagnosed with GERD in childhood between 1990 and 1996. We excluded patients with comorbid illnesses. Eligible persons were contacted by telephone in person or through a household member and requested to complete a validated (in adults) symptom questionnaire between February 2001 and February 2003. Respondents were invited to undergo an upper endoscopy or to share results of any endoscopic examination performed within the past 12 months. We calculated the proportion of persons with GERD symptoms (monthly, weekly), and with current use of antisecretory medications (histamine-2-receptor antagonists [H2RA], proton pump inhibitors [PPI]). RESULTS: A total of 207 persons satisfied the inclusion and exclusion criteria and were contacted. Of those, 80 (39%) completed the questionnaire and 14/80 (18%) had an upper endoscopy. The mean age of participants was 20 years (SD = 4, range 10-40); most were Caucasian (73%), and 60% were female. GERD was documented at a mean age of 5 years (approximately a 15-yr duration of follow-up). Most participants (64/80, 80%) had at least monthly heartburn and/or acid regurgitation reported within the past 12 months; 18/80 (23%) reported at least weekly symptoms, and an additional three patients were asymptomatic but taking antisecretory therapy (H2RA or PPI). If all nonresponders were considered free of symptoms, then at least 31% had monthly symptoms, and 9% had weekly symptoms. Overall, 24 (30%) were currently taking either H2RA or PPI, and 19 patients had undergone fundoplication. There were no statistically significant differences between those who reported monthly GERD symptoms, weekly GERD symptoms, or no GERD symptoms as far as demographic features, age of GERD onset, receipt of fundoplication, or current GERD treatment. At endoscopy, three patients had mild to moderate erosive esophagitis. CONCLUSIONS: GERD in otherwise normal children can persist through adolescence and adulthood in a significant proportion of patients who continue to have GERD symptoms and signs, and use antisecretory medications. Childhood GERD is a risk factor for GERD in adolescence and adulthood.
目的:无合并症(神经功能缺陷、先天性食管异常、慢性阻塞性气道疾病)的儿童胃食管反流病(GERD)的临床病程尚不清楚。儿童期GERD是否会进展或导致成年期GERD仍不明确。 方法:我们确定了一组在1990年至1996年期间经内镜诊断为儿童GERD的个体。我们排除了有合并症的患者。在2001年2月至2003年2月期间,通过电话亲自联系或通过家庭成员联系符合条件的人,并要求他们完成一份经过验证的(针对成年人的)症状问卷。邀请受访者接受上消化道内镜检查或分享过去12个月内进行的任何内镜检查结果。我们计算了有GERD症状(每月、每周)以及目前使用抗分泌药物(组胺-2受体拮抗剂 [H2RA]、质子泵抑制剂 [PPI])的人群比例。 结果:共有207人符合纳入和排除标准并被联系。其中,80人(39%)完成了问卷,14/80人(18%)接受了上消化道内镜检查。参与者的平均年龄为20岁(标准差 = 4,范围10 - 40岁);大多数是白种人(73%),60%为女性。GERD记录的平均年龄为5岁(随访时间约15年)。大多数参与者(64/80,80%)在过去12个月内至少每月有烧心和/或反酸症状;18/80人(23%)报告至少每周有症状,另外3名患者无症状但正在接受抗分泌治疗(H2RA或PPI)。如果将所有未回复者视为无症状,则至少31%的人每月有症状,9%的人每周有症状。总体而言,24人(30%)目前正在服用H2RA或PPI,19名患者接受了胃底折叠术。在人口统计学特征、GERD发病年龄、接受胃底折叠术或目前的GERD治疗方面,报告每月GERD症状、每周GERD症状或无GERD症状的人群之间没有统计学上的显著差异。在内镜检查中,3名患者有轻度至中度糜烂性食管炎。 结论:在其他方面正常的儿童中,相当一部分患者的GERD会持续到青春期和成年期,这些患者仍有GERD症状和体征,并使用抗分泌药物。儿童期GERD是青春期和成年期GERD的一个危险因素。
Am J Gastroenterol. 2004-5
Clin Gastroenterol Hepatol. 2007-6
Thorac Surg Clin. 2005-8
Am J Gastroenterol. 2005-6
J Pediatr Gastroenterol Nutr. 2008-8
Am J Gastroenterol. 2003-10
Int J Mol Sci. 2017-8-1
Korean J Pediatr. 2016-7
Postgrad Med J. 2015-1
Pediatr Gastroenterol Hepatol Nutr. 2012-12
World J Gastrointest Endosc. 2012-8-16
Ann Epidemiol. 2012-3-3